# FDA Inspection 1069265 - Sage Therapeutics, Inc. - September 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/sage-therapeutics-inc/6e51fe28-ae66-42b2-8331-27b022e49a35
Source feed: FDA_Inspections

> FDA Inspection 1069265 for Sage Therapeutics, Inc. on September 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069265
- Company Name: Sage Therapeutics, Inc.
- Inspection Date: 2018-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1180570 - 2022-09-21](https://www.keypedia.com/records/fda_inspections/sage-therapeutics-inc/e5f65ae7-2110-4fad-b3e5-5599d46e3cfb)

Company: https://www.keypedia.com/companies/sage-therapeutics-inc/a4cede95-98e8-4915-9d60-d91f89366850

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c